- Home
- PRTA vs ALLT Comparison
PRTA vs ALLT Comparison
Compare PRTA & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ALLT
- Stock Information
- Founded
- PRTA 2012
- ALLT 1996
- Country
- PRTA Ireland
- ALLT Israel
- Employees
- PRTA N/A
- ALLT N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ALLT Telecommunications Equipment
- Sector
- PRTA Health Care
- ALLT Telecommunications
- Exchange
- PRTA Nasdaq
- ALLT Nasdaq
- Market Cap
- PRTA 472.1M
- ALLT 342.5M
- IPO Year
- PRTA N/A
- ALLT 2006
- Fundamental
- Price
- PRTA $8.20
- ALLT $7.86
- Analyst Decision
- PRTA Buy
- ALLT Buy
- Analyst Count
- PRTA 10
- ALLT 1
- Target Price
- PRTA $14.86
- ALLT N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- ALLT 535.2K
- Earning Date
- PRTA 08-04-2025
- ALLT 08-14-2025
- Dividend Yield
- PRTA N/A
- ALLT N/A
- EPS Growth
- PRTA N/A
- ALLT N/A
- EPS
- PRTA N/A
- ALLT N/A
- Revenue
- PRTA $10,341,000.00
- ALLT $95,342,000.00
- Revenue This Year
- PRTA N/A
- ALLT $10.64
- Revenue Next Year
- PRTA $389.77
- ALLT $15.76
- P/E Ratio
- PRTA N/A
- ALLT N/A
- Revenue Growth
- PRTA N/A
- ALLT 4.74
- 52 Week Low
- PRTA $4.32
- ALLT $2.75
- 52 Week High
- PRTA $22.83
- ALLT $10.77
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- ALLT 51.18
- Support Level
- PRTA $8.05
- ALLT $7.71
- Resistance Level
- PRTA $8.73
- ALLT $8.10
- Average True Range (ATR)
- PRTA 0.38
- ALLT 0.44
- MACD
- PRTA -0.05
- ALLT 0.09
- Stochastic Oscillator
- PRTA 47.62
- ALLT 59.12
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.